Covaxin effectively neutralises all key emerging variants, says study published in Oxford journal, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

A top official of the company also said that no difference in neutralisation was observed between B.1.1.7 (first isolated in the UK) and vaccine strain (D614G) that was used to develop Covaxin., A top official of the company also said that no difference in neutralisation was observed between B.1.1.7 (first isolated in the UK) and vaccine strain (D614G) that was used to develop Covaxin., , Read More